Vimarsana
Biggest News Aggregation in the World

Page 11 - Listing Qualifications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Listing Qualifications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Listing Qualifications Today - Breaking & Trending Today

Enthusiast Gaming Receives 180-day Extension to NASDAQ Minimum Bid Price Deficiency Deadline - Vimarsana News

Enthusiast Gaming Receives 180-day Extension to NASDAQ Minimum Bid Price Deficiency Deadline

LOS ANGELES, May 04, 2023 -- Enthusiast Gaming Holdings Inc. today announced that on May 3, 2023, the Listing Qualifications department of the Nasdaq Stock Market LLC approved the... | May 4, 2023

Nexters : Receives Notice of Noncompliance with Nasdaq Listing Rules - Form 6-K - Vimarsana News

Nexters : Receives Notice of Noncompliance with Nasdaq Listing Rules - Form 6-K

Nexters Receives Notice of Noncompliance with Nasdaq Listing Rules On May 2, 2023, Nexters Inc. , an international game development company , received a notification letter from... | May 3, 2023

Nexters : Receives Notice of Noncompliance with Nasdaq Listing Rules - Vimarsana News

Nexters : Receives Notice of Noncompliance with Nasdaq Listing Rules

Nexters Receives Notice of Noncompliance with Nasdaq Listing Rules On May 2, 2023, Nexters Inc. , an international game development company , received a notification letter from... | May 3, 2023

EVELO BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) - Vimarsana News

EVELO BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 25, 2023, Evelo Biosciences, Inc. received a letter from the Listing... | May 1, 2023

Aridis Pharmaceuticals Receives Nasdaq Notice on Late - Vimarsana News

Aridis Pharmaceuticals Receives Nasdaq Notice on Late

LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical...